HC Wainwright reissued their buy rating on shares of Vir Biotechnology (NASDAQ:VIR – Free Report) in a research note published on Friday, Benzinga reports. They currently have a $110.00 price objective on the stock. A number of other research firms have also weighed in on VIR. JPMorgan Chase & Co. boosted their target price on […]
Vanguard Capital Wealth Advisors decreased its stake in Nautilus Biotechnology, Inc. (NASDAQ:NAUT – Free Report) by 13.0% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 40,000 shares of the company’s stock after selling 6,000 shares during the period. Vanguard Capital […]
Sana Biotechnology (NASDAQ:SANA) Stock Price Down 3.8% theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Puma Biotechnology (NASDAQ:PBYI – Get Free Report) was downgraded by analysts at StockNews.com from a “buy” rating to a “hold” rating in a note issued to investors on Wednesday. Separately, HC Wainwright reduced their target price on Puma Biotechnology from $8.00 to $7.00 and set a “buy” rating on the stock in a research report […]
Vir Biotechnology, Inc. (NASDAQ:VIR – Get Free Report) CEO Backer Marianne De sold 72,995 shares of the business’s stock in a transaction that occurred on Wednesday, April 3rd. The stock was sold at an average price of $9.46, for a total value of $690,532.70. Following the sale, the chief executive officer now directly owns 678,457 […]